162
Department of Health and Human Services for the purpose
of any limitation on the number of such employees estab-
lished by law prior to, on, or after the date of the enactment
of the National Institutes of Health Revitalization Act of
1993.
‘‘(e) REPORT TO CONGRESS.—Not later than February
1 of each fiscal year, the Director of the Office shall submit
to the Committee on Energy and Commerce of the House
of Representatives, and to the Committee on Labor and
Human Resources of the Senate, a report on the AIDS
projects carried out during the preceding fiscal year with
amounts in the Fund. The report shall provide a descrip-
tion of each such project and an explanation of the reasons
underlying the use of the Fund for the project.
‘‘(f) DEFINITIONS.—For purposes of this section:
‘‘(1) The term ‘AIDS project’ means a project de-
scribed in subsection (a).
‘‘(2) The term ‘Fund’ means the fund established
in subsection (a).
‘‘(g) FUNDING.—
‘‘(1) AUTHORIZATION OF APPROPRIATIONS.—For
the purpose of providing amounts for the Fund, there
is authorized to be appropriated $100,000,000 for
each of the fiscal years 1994 through 1996.
163
‘‘(2) AVAILABILITY.—Amounts appropriated for
the Fund are available until expended.’’.
SEC. 1803. GENERAL PROVISIONS.
Part D of title XXIII of the Public Health Service Act,
as amended by section 1802 of this Act, is amended by add-
ing at the end the following subpart:
‘‘Subpart III—General Provisions
‘‘SEC. 2359. GENERAL PROVISIONS REGARDING THE OF-
FICE.
‘‘(a) ADMINISTRATIVE SUPPORT FOR OFFICE.—The
Secretary, acting through the Director of the National Insti-
tutes of Health, shall provide administrative support and
support services to the Director of the Office.
‘‘(b) DEFINITIONS.—For purposes of this part:
‘‘(1) The term ‘AIDS activities’ means AIDS re-
search and other activities that relate to acquired im-
mune deficiency syndrome.
‘‘(2) The term ‘AIDS research’ means research
with respect to acquired immune deficiency syndrome.
‘‘(3) The term ‘Office’ means the Office of AIDS
Research.
‘‘(4) The term ‘Plan’ means the plan required in
section 2353(a)(1).’’.
164
Subtitle B—Certain Programs
SEC. 1811. REVISION AND EXTENSION OF CERTAIN PRO-
GRAMS.
Title XXIII of the Public Health Service Act (42
U.S.C. 300cc et seq.) is amended—
(1) in section 2304(c)(1)—
(A) in the matter preceding subparagraph
(A), by inserting after ‘‘Director of such Insti-
tute’’ the following: ‘‘(and may provide advice to
the Directors of other agencies of the National
Institutes of Health, as appropriate)’’; and
(B) in subparagraph (A), by inserting be-
fore the semicolon the following: ‘‘, including rec-
ommendations on the projects of research with
respect to diagnosing immune deficiency and
with respect to predicting, diagnosing, prevent-
ing, and treating opportunistic cancers and in-
fectious diseases’’;
(2) in section 2311(a)(1), by inserting before the
semicolon the following: ‘‘, including evaluations of
methods of diagnosing immune deficiency and evalua-
tions of methods of predicting, diagnosing, preventing,
and treating opportunistic cancers and infectious
diseases’’;
(3) in section 2315—
165
(A) in subsection (a)(2), by striking ‘‘inter-
national research’’ and all that follows and in-
serting ‘‘international research and training
concerning the natural history and pathogenesis
of the human immunodeficiency virus and the
development and evaluation of vaccines and
treatments for acquired immune deficiency syn-
drome and opportunistic infections.’’; and
(B) in subsection (f), by striking ‘‘there are
authorized’’ and all that follows and inserting
‘‘there are authorized to be appropriated such
sums as may be necessary for each fiscal year.’’;
(4) in section 2318—
(A) in subsection (a)(1)—
(i) by inserting after ‘‘The Secretary’’
the following: ‘‘, acting through the Director
of the National Institutes of Health and
after consultation with the Administrator
for Health Care Policy and Research,’’; and
(ii) by striking ‘‘syndrome’’ and insert-
ing ‘‘syndrome, including treatment and
prevention of HIV infection and related
conditions among women’’; and
(B) in subsection (e), by striking ‘‘1991.’’
and inserting the following: ‘‘1991, and such
166
sums as may be necessary for each of the fiscal
years 1994 through 1996.’’;
(5) in section 2320(b)(1)(A), by striking ‘‘syn-
drome’’ and inserting ‘‘syndrome and the natural his-
tory of such infection’’;
(6) in section 2320(e)(1), by striking ‘‘there are
authorized’’ and all that follows and inserting ‘‘there
are authorized to be appropriated such sums as may
be necessary for each fiscal year.’’;
(7) in section 2341(d), by striking ‘‘there are au-
thorized’’ and all that follows and inserting ‘‘there are
authorized to be appropriated such sums as may be
necessary for each fiscal year.’’; and
(8) in section 2361, by striking ‘‘For purposes’’
and all that follows and inserting the following:
‘‘For purposes of this title:
‘‘(1) The term ‘infection’, with respect to the etio-
logic agent for acquired immune deficiency syndrome,
includes opportunistic cancers and infectious diseases
and any other conditions arising from infection with
such etiologic agent.
‘‘(2) The term ‘treatment’, with respect to the
etiologic agent for acquired immune deficiency syn-
drome, includes primary and secondary prophy-
laxis.’’;
167
TITLE XIX—STUDIES
SEC. 1901. ACQUIRED IMMUNE DEFICIENCY SYNDROME.
(a) THIRD-PARTY PAYMENTS REGARDING CERTAIN
CLINICAL TRIALS.—The Secretary of Health and Human
Services, acting through the Director of the National Insti-
tutes of Health, shall conduct a study for the purpose of—
(1) determining the policies of third-party
payors regarding the payment of the costs of appro-
priate health services that are provided incident to
the participation of individuals as subjects in clinical
trials conducted in the development of drugs with re-
spect to acquired immune deficiency syndrome; and
(2) developing recommendations regarding such
policies.
(b) ADVISORY COMMITTEES.—The Secretary of Health
and Human Services, acting through the Director of the Na-
tional Institutes of Health, shall conduct a study for the
purpose of determining—
(1) whether the activities of the various advisory
committees established in the National Institutes of
Health regarding acquired immune deficiency syn-
drome are being coordinated sufficiently; and
(2) whether the functions of any of such advisory
committees should be modified in order to achieve
greater efficiency.